Your browser doesn't support javascript.
loading
Computational study of novel natural inhibitors targeting Kirsten rat sarcoma viral oncogene homolog G12C.
Yang, Wenzhuo; Ge, Junliang; Yuan, Meng; Li, Jialin; Pan, Lin; Ren, Junan; Dou, Gaojing; Yang, Laiyu; Zhou, Yang; Xie, Haoqun; Wang, Xinhui; Hu, Hongrong.
Affiliation
  • Yang W; Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou.
  • Ge J; Department of Neurology, First Hospital of Jilin University.
  • Yuan M; Department of Oncology, The Second Hospital of Jilin University.
  • Li J; Department of Oncology, The Second Hospital of Jilin University.
  • Pan L; Department of Neurology, First Hospital of Jilin University.
  • Ren J; Department of Oncology, The Second Hospital of Jilin University.
  • Dou G; Department of Breast Surgery, the First Hospital of Jilin University, Changchun.
  • Yang L; Department of Oncology, The Second Hospital of Jilin University.
  • Zhou Y; Department of Oncology, The Second Hospital of Jilin University.
  • Xie H; Department of Oncology, The Second Hospital of Jilin University.
  • Wang X; Department of Oncology, Xinxiang Medical College, Xinxiang, China.
  • Hu H; Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou.
Anticancer Drugs ; 34(5): 609-619, 2023 06 01.
Article in En | MEDLINE | ID: mdl-36847041

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma of Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma of Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2023 Type: Article